229 related articles for article (PubMed ID: 10692750)
41. Oral garenoxacin in the treatment of acute bacterial maxillary sinusitis: a Phase II, multicenter, noncomparative, open-label study in adult patients undergoing sinus aspiration.
Lopez Sisniega J; Profant M; Kostrica R; Waskin H
Clin Ther; 2007 Aug; 29(8):1632-44. PubMed ID: 17919545
[TBL] [Abstract][Full Text] [Related]
42. Clarithromycin versus cefaclor in lower respiratory tract infections. The Canadian Bronchitis Study Group.
Fong IW; Laforge J; Dubois J; Small D; Grossman R; Zakhari R
Clin Invest Med; 1995 Apr; 18(2):131-8. PubMed ID: 7788958
[TBL] [Abstract][Full Text] [Related]
43. Levofloxacin 750 mg QD for five days versus amoxicillin/clavulanate 875 mg/125 mg BID for ten days for treatment of acute bacterial exacerbation of chronic bronchitis: a post hoc analysis of data from severely ill patients.
Grossman RF; Ambrusz ME; Fisher AC; Khashab MM; Kahn JB
Clin Ther; 2006 Aug; 28(8):1175-1180. PubMed ID: 16982294
[TBL] [Abstract][Full Text] [Related]
44. Randomized, double-blind study of grepafloxacin versus amoxycillin in patients with acute bacterial exacerbations of chronic bronchitis.
Langan CE; Cranfield R; Breisch S; Pettit R
J Antimicrob Chemother; 1997 Dec; 40 Suppl A():63-72. PubMed ID: 9484875
[TBL] [Abstract][Full Text] [Related]
45. Randomised controlled trial of amoxycillin clavulanate in children with chronic wet cough.
Marchant J; Masters IB; Champion A; Petsky H; Chang AB
Thorax; 2012 Aug; 67(8):689-93. PubMed ID: 22628120
[TBL] [Abstract][Full Text] [Related]
46. Three vs. 10 days of amoxycillin-clavulanic acid for type 1 acute exacerbations of chronic obstructive pulmonary disease: a randomised, double-blind study.
Roede BM; Bresser P; El Moussaoui R; Krouwels FH; van den Berg BT; Hooghiemstra PM; de Borgie CA; Speelman P; Bossuyt PM; Prins JM
Clin Microbiol Infect; 2007 Mar; 13(3):284-90. PubMed ID: 17391383
[TBL] [Abstract][Full Text] [Related]
47. A comparison of cefaclor and tetracycline in the treatment of bacterial bronchitis.
Hurst DJ
Clin Ther; 1984; 6(2):163-9. PubMed ID: 6231104
[TBL] [Abstract][Full Text] [Related]
48. Treatment of acute bronchitis and pneumonia with cefaclor.
Mattson K; Renkonen OV; Laitinen L; Nikander-Hurme R
Postgrad Med J; 1979; 55 Suppl 4():59-61. PubMed ID: 398482
[TBL] [Abstract][Full Text] [Related]
49. Efficacy and safety of twice-daily pharmacokinetically enhanced amoxicillin/clavulanate (2000/125 mg) in the treatment of adults with community-acquired pneumonia in a country with a high prevalence of penicillin-resistant Streptococcus pneumoniae.
Siquier B; Sánchez-Alvarez J; García-Mendez E; Sabriá M; Santos J; Pallarés R; Twynholm M; Dal-Ré R;
J Antimicrob Chemother; 2006 Mar; 57(3):536-45. PubMed ID: 16446376
[TBL] [Abstract][Full Text] [Related]
50. Gemifloxacin versus amoxicillin/clavulanate in the treatment of acute exacerbations of chronic bronchitis. The 070 Clinical Study group.
File T; Schlemmer B; Garau J; Lode H; Lynch S; Young C
J Chemother; 2000 Aug; 12(4):314-25. PubMed ID: 10949981
[TBL] [Abstract][Full Text] [Related]
51. A comparative study of clarithromycin modified release and amoxicillin/clavulanic acid in the treatment of acute exacerbation of chronic bronchitis.
Martinot JB; Carr WD; Cullen S; Heredia Budo JL; Bauer K; MacLeod C; Sanguinetti CM; van Veldhuizen WC;
Adv Ther; 2001; 18(1):1-11. PubMed ID: 11512528
[TBL] [Abstract][Full Text] [Related]
52. Efficacy of twice-daily amoxycillin/clavulanate ('Augmentin-Duo' 400/57) in mild to moderate lower respiratory tract infection in children.
Cook RC; Zachariah J; Cree F; Harrison HE
Br J Clin Pract; 1996; 50(3):125-8. PubMed ID: 8733329
[TBL] [Abstract][Full Text] [Related]
53. Review of the spectrum and potency of orally administered cephalosporins and amoxicillin/clavulanate.
Sader HS; Jacobs MR; Fritsche TR
Diagn Microbiol Infect Dis; 2007 Mar; 57(3 Suppl):5S-12S. PubMed ID: 17292577
[TBL] [Abstract][Full Text] [Related]
54. Short-course therapy of acute bacterial exacerbation of chronic bronchitis: a double-blind, randomized, multicenter comparison of extended-release versus immediate-release clarithromycin.
Nalepa P; Dobryniewska M; Busman T; Notario G
Curr Med Res Opin; 2003; 19(5):411-20. PubMed ID: 13678478
[TBL] [Abstract][Full Text] [Related]
55. A comparative study of cefaclor vs amoxicillin/clavulanate in pediatric pharyngotonsillitis.
Haczyński J; Chmielik M; Bien S; Kawalski H; Zawadzka-Głos L; Mierzwa T; Zyłka S; Moś M; Szendo-Kita J; Mozejko-Pastewka B; Czarnocki KJ; Rek M
Med Sci Monit; 2003 Mar; 9(3):PI29-35. PubMed ID: 12640354
[TBL] [Abstract][Full Text] [Related]
56. Moxifloxacin versus amoxicillin clavulanate in the treatment of acute maxillary sinusitis: a primary care experience.
Rakkar S; Roberts K; Towe BF; Flores SM; Heyd A; Warner J
Int J Clin Pract; 2001 Jun; 55(5):309-15. PubMed ID: 11452678
[TBL] [Abstract][Full Text] [Related]
57. [Clinical contribution of the newer fluoroquinolones in acute bacterial exacerbation of chronic bronchitis].
Niederman MS
Medicina (B Aires); 1999; 59 Suppl 1():23-30. PubMed ID: 10436551
[TBL] [Abstract][Full Text] [Related]
58. Clinical comparison of cefaclor twice daily versus amoxicillin-clavulanate or erythromycin three times daily in the treatment of patients with streptococcal pharyngitis.
Esposito S; De Ritis G; D'Errico G; Noviello S; Ianniello F
Clin Ther; 1998; 20(1):72-9. PubMed ID: 9522105
[TBL] [Abstract][Full Text] [Related]
59. A double-blind comparison of the effects of cefaclor and amoxycillin on respiratory tract and oropharyngeal flora and clinical response in acute exacerbations of bronchitis.
Trigg CJ; Wilks M; Herdman MJ; Clague JE; Tabaqchali S; Davies RJ
Respir Med; 1991 Jul; 85(4):301-8. PubMed ID: 1947367
[TBL] [Abstract][Full Text] [Related]
60. Comparative efficacy of once daily, 5-day short-course therapy with clarithromycin extended-release versus twice daily, 7-day therapy with clarithromycin immediate-release in acute bacterial exacerbation of chronic bronchitis.
Gotfried M; Notario G; Spiller J; Palmer R; Busman T
Curr Med Res Opin; 2005 Feb; 21(2):245-54. PubMed ID: 15801995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
